Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Kwanza Price"'
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Kwanza Price,1 Zhun Cao,2 Craig Lipkin,2 Deb Profant,1 Scott Robinson2 1Jazz Pharmaceuticals, Palo Alto, CA, USA; 2Premier Inc., Charlotte, NC, USACorrespondence: Deb ProfantJazz Pharmaceuticals, 3170 Porter Dr., Palo Alto, CA, 94304, USATel/Fax +1 9
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 24:4-11
Anticitrullinated protein antibodies (ACPAs) are serological biomarkers associated with early, rapidly progressing rheumatoid arthritis (RA), including more severe disease and joint damage. ACPA testing has become a routine tool for RA diagnosis and
Autor:
Kelly Clapp, Lauren Ashka, Kacper Perkowski, Kwanza Price, Halley Costantino, Bryan Inyart, Russell L. Knoth, Shaloo Gupta
Publikováno v:
Blood. 138:4062-4062
Introduction: A recent systematic literature review (Betts M, et al . Clin Ther 2020;42:322-337) perceived that in the past 2 decades, advancements in the treatment and management of β-thalassemia have resulted in improvements in iron control. Howev
Autor:
Kacper Perkowski, Russell L. Knoth, Kwanza Price, Lauren Ashka, Bryan Inyart, Shaloo Gupta, Halley Costantino, Kelly Clapp
Publikováno v:
Blood. 138:4987-4987
Introduction: β-thalassemia is a genetic blood disorder marked by the inability to produce hemoglobin. Diagnosed primarily in childhood, transfusion-dependent β-thalassemia (TDT) is the most severe form of this disorder and results in chronic anemi
Autor:
Talia Miller, Sudipto Mukherjee, Kristin M. Zimmerman Savill, Angelica Falkenstein, Cherrishe Brown-Bickerstaff, Jonathan Kish, Jalyna R. Laney, Ajeet Gajra, Kwanza Price
Publikováno v:
Blood. 138:4657-4657
Introduction: Myelodysplastic syndromes (MDS) comprise a group of clonal hematopoietic disorders characterized by ineffective hematopoiesis, cytopenias, dysplasia in ≥ 1 cell line, cytogenetic and molecular abnormalities, and variable risk of progr
Autor:
Huai-Che Shih, Michael Eaddy, Harris A. Ahmad, Lois Lamerato, Kwanza Price, Rick Szymialis, Augustina Ogbonnaya
Publikováno v:
Journal of Medical Economics. 21:231-240
Anti-cyclic citrullinated peptide (CCP) antibody positivity is an established diagnostic factor for severe disease activity and joint damage and a prognostic factor for aggressive disease in rheumatoid arthritis (RA).To compare RA-related treatment,
Autor:
Henry J. Henk, Shalabh Singhal, Lien Vo, Kenneth Tuell, Feng Cao, Jeffrey Trocio, Chad Patel, Jack Mardekian, Kevin Odell, Kwanza Price, Prianka Singh, Wilson Tan, Sands George Harry
Publikováno v:
Current medical research and opinion. 34(3)
Objective To evaluate inpatient oral anticoagulant (OAC) treatment, discharge location, and post-discharge OAC treatment for patients hospitalized with non-valvular atrial fibrillation (NVAF). Research design and methods Retrospective study using cla
Publikováno v:
Poster Presentations.
Background Current treatments for psoriatic arthritis (PsA) are associated with a range of limitations, e.g. side effects, safety concerns and inadequate efficacy. The economic burden of biologic (b)DMARD failure among patients (pts) with PsA is thou
Autor:
Y Doleh, A Szymialis, Kwanza Price, A Ogbonnaya, Lois Lamerato, Harris A. Ahmad, M Eaddy, H-C Shih
Publikováno v:
Poster Presentations.
Background Patients with RA who are at a higher risk for progressive and destructive arthritis could be identified using anti-cyclic citrullinated peptide (anti-CCP) levels. 1 Treatment guidelines recommend the use of non-biologic DMARDs as initial t
Autor:
Lisa Rosenblatt, Ningqi Hou, Jason Shafrin, Mahlet Gizaw Tebeka, Kaleb Michaud, Kwanza Price, Chad Patel
Publikováno v:
Rheumatology. 56